Michelle Van Name

2.8k total citations
53 papers, 1.2k citations indexed

About

Michelle Van Name is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Michelle Van Name has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Surgery and 17 papers in Genetics. Recurrent topics in Michelle Van Name's work include Diabetes Management and Research (35 papers), Pancreatic function and diabetes (26 papers) and Diabetes and associated disorders (16 papers). Michelle Van Name is often cited by papers focused on Diabetes Management and Research (35 papers), Pancreatic function and diabetes (26 papers) and Diabetes and associated disorders (16 papers). Michelle Van Name collaborates with scholars based in United States, Italy and Denmark. Michelle Van Name's co-authors include William V. Tamborlane, Lori M. Laffel, Sonia Caprio, Linda A. DiMeglio, Barbara J. Anderson, Mary Savoye, Kellee M. Miller, Nicola Santoro, Daniel J. DeSalvo and Marisa E. Hilliard and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Michelle Van Name

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Van Name United States 22 939 492 424 189 163 53 1.2k
Margarita Barrientos‐Pérez United States 11 828 0.9× 307 0.6× 145 0.3× 310 1.6× 81 0.5× 24 1.3k
Aya Morimoto Japan 18 321 0.3× 120 0.2× 107 0.3× 148 0.8× 137 0.8× 49 848
Paul Gard United Kingdom 10 328 0.3× 299 0.6× 39 0.1× 140 0.7× 90 0.6× 22 1.1k
Diana Guthrie United States 13 344 0.4× 75 0.2× 91 0.2× 56 0.3× 59 0.4× 40 652
Katherine Semenkovich United States 8 276 0.3× 75 0.2× 80 0.2× 73 0.4× 91 0.6× 16 501
Mário Sérgio Soares de Azeredo Coutinho Brazil 10 986 1.1× 191 0.4× 124 0.3× 227 1.2× 186 1.1× 23 1.6k
Plácido Llaneza Spain 20 475 0.5× 42 0.1× 204 0.5× 131 0.7× 96 0.6× 50 1.1k
Ingela K. Wiklund Sweden 13 86 0.1× 389 0.8× 71 0.2× 194 1.0× 95 0.6× 18 1.1k
Michaela Kleber Germany 17 281 0.3× 62 0.1× 83 0.2× 258 1.4× 109 0.7× 27 983
Sara Richter United States 18 189 0.2× 56 0.1× 130 0.3× 53 0.3× 44 0.3× 39 729

Countries citing papers authored by Michelle Van Name

Since Specialization
Citations

This map shows the geographic impact of Michelle Van Name's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Van Name with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Van Name more than expected).

Fields of papers citing papers by Michelle Van Name

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Van Name. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Van Name. The network helps show where Michelle Van Name may publish in the future.

Co-authorship network of co-authors of Michelle Van Name

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Van Name. A scholar is included among the top collaborators of Michelle Van Name based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Van Name. Michelle Van Name is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Name, Michelle Van, Björg Ásbjörnsdóttir, Marília Brito Gomes, et al.. (2025). Pharmacokinetic Properties of Once‐Weekly Insulin Icodec in Children and Adolescents With Type 2 Diabetes. Pediatric Diabetes. 2025(1). 1 indexed citations
2.
Ekhlaspour, Laya, Bruce A. Buckingham, Mark A. Clements, et al.. (2024). Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience. Journal of Clinical & Translational Endocrinology. 36. 100352–100352. 2 indexed citations
3.
Wolf, Risa M., Peiyao Cheng, Robin L. Gal, et al.. (2022). Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study. Pediatric Diabetes. 23(4). 439–446. 3 indexed citations
4.
Weinzimer, Stuart A., et al.. (2022). Technology Utilization in Black Adolescents with Type 1 Diabetes: Exploring the Decision-Making Process. Diabetes Technology & Therapeutics. 24(4). 249–257. 23 indexed citations
5.
Tamborlane, William V., Lori M. Laffel, Naim Shehadeh, et al.. (2022). Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. The Lancet Diabetes & Endocrinology. 10(5). 341–350. 47 indexed citations
6.
7.
Cline, Gary W., Michelle Van Name, Veronika Shabanova, et al.. (2021). Colonic Fermentation and Acetate Production in Youth with and without Obesity. Journal of Nutrition. 151(11). 3292–3298. 6 indexed citations
8.
DiMeglio, Linda A., Lauren Kanapka, Daniel J. DeSalvo, et al.. (2020). Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabetic Medicine. 37(8). 1308–1315. 16 indexed citations
9.
Commissariat, Persis, Marisa E. Hilliard, Kellee M. Miller, et al.. (2020). Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes. Diabetes Technology & Therapeutics. 22(9). 697–700. 7 indexed citations
10.
Name, Michelle Van, Mary Savoye, Ariel E. Feldstein, et al.. (2020). A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth. Journal of Nutrition. 150(9). 2314–2321. 57 indexed citations
11.
Tarabra, Elena, Jessica Nouws, Geoffrey Nadzam, et al.. (2020). The omentum of obese girls harbors small adipocytes and browning transcripts. JCI Insight. 5(6). 8 indexed citations
12.
Name, Michelle Van, Peiyao Cheng, Robin L. Gal, et al.. (2020). Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control. Diabetic Medicine. 37(5). 863–867. 12 indexed citations
13.
Alessi, Sheila M., Nicole C. Foster, Carla J. Rash, et al.. (2020). Alcohol Use and Clinical Outcomes in Adults in the Type 1 Diabetes Exchange. Canadian Journal of Diabetes. 44(6). 501–506. 2 indexed citations
14.
Commissariat, Persis, Kara R. Harrington, Kellee M. Miller, et al.. (2019). “I'm essentially his pancreas”: Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes. Pediatric Diabetes. 21(2). 377–383. 66 indexed citations
15.
Hilliard, Marisa E., Wendy Levy, Barbara J. Anderson, et al.. (2019). Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 21(9). 493–498. 94 indexed citations
16.
Name, Michelle Van, Georgeanna J. Klingensmith, Bryce Nelson, et al.. (2019). Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model. Diabetes Technology & Therapeutics. 22(4). 330–336. 5 indexed citations
17.
Tamborlane, William V., Pei-Yao Chang, Craig Kollman, et al.. (2018). Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatric Diabetes. 19(8). 1379–1384. 11 indexed citations
18.
Name, Michelle Van, Marisa E. Hilliard, Claire T. Boyle, et al.. (2018). Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. PMC. 4 indexed citations
19.
Cengiz, Eda, Bruce W. Bode, Michelle Van Name, & William V. Tamborlane. (2015). Moving toward the ideal insulin for insulin pumps. Expert Review of Medical Devices. 13(1). 57–69. 31 indexed citations
20.
Name, Michelle Van & Sonia Caprio. (2013). Reliable Assessment of Insulin Resistance in Children. Current Cardiovascular Risk Reports. 7(4). 256–260. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margarita Barrientos‐Pérez Breakdown of academic impact, for papers by Aya Morimoto Breakdown of academic impact, for papers by Paul Gard Breakdown of academic impact, for papers by Diana Guthrie Breakdown of academic impact, for papers by Katherine Semenkovich Breakdown of academic impact, for papers by Mário Sérgio Soares de Azeredo Coutinho Breakdown of academic impact, for papers by Plácido Llaneza Breakdown of academic impact, for papers by Ingela K. Wiklund Breakdown of academic impact, for papers by Michaela Kleber Breakdown of academic impact, for papers by Sara Richter
Rankless by CCL
2026